FOXA2 and obesity disorder: Although the evidence presented in this study suggests that modulation of Foxa2 in intestinal epithelial cells has therapeutic effects on high-fat diet induced obesity and diabetes, cell type specific Foxa2 genomic distribution profiles, transcriptional outcomes, and biological functions need to be further investigated in the future studies.